GOG Foundation

 

GOG Foundation
C

PARPi Monotherapy w/ Olaparib or Talazoparib Has Established Role as an Alternative to Chemotherapy for gBRCA and HER2- Metastatic Breast Cancer

By GOG Foundation FEATURING Charles Geyer
By GOG Foundation FEATURING Charles Geyer
404 views
January 22, 2020
Comments 0
Login to view comments. Click here to Login
Winter 2020 Symposium “It’s a PARP World After All”
10:32

PARPi Benefit in Ovarian Cancer: Does PARPi Maintenance Prolong PFS …

GOG Foundation

J. Liu

249 views
09:08

Maintenance Therapy Clinical Trials in Newly Diagnosed Ovarian Cance…

GOG Foundation

J. Liu

413 views
05:55

Frontline Maintenance Therapy With PARPi is the Standard of Care in …

GOG Foundation

K. Moore

512 views
09:34

Clinically-Guided Interventions and New Clinical Trials Are Preferre…

GOG Foundation

M. Bookman

86 views
03:01

Frontline Maintenance Therapy With PARPi is the Standard of Care in …

GOG Foundation

K. Moore

192 views
06:03

Expanding PARPi Horizons in Gynecological Cancers: Will Women With E…

GOG Foundation

B. Rimel

65 views
08:20

Expanding PARPi Horizons in Gynecological Cancers: Cervical Cancer C…

GOG Foundation

R. Salani

29 views
16:52

Future of Clinical Trial Design in the New PARPi World in Gynecologi…

GOG Foundation

R. Coleman

34 views
20:06

PARPi Monotherapy w/ Olaparib or Talazoparib Has Established Role as…

GOG Foundation

C. Geyer

404 views
05:52

PARPi Are an Excellent Oral Option w/ Quick Time Response and Improv…

GOG Foundation

J. Litton

500 views
10:11

Atezolizumab + nab-Paclitaxel Confers PFS/OS in PD-L1+ mTNBC as a Ne…

GOG Foundation

L. Emens

191 views
24:23

PARPi as Monotherapy Have High-Level Anti-Tumor Activity in mCRPC w/…

GOG Foundation

O. Sartor

163 views
31:56

New Frontiers of PARPi Therapy in Pancreatic and Biliary Cancers: Tu…

GOG Foundation

J. Abbruzzese

425 views